Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1CNS 1

Conditions

Sexual Infantilism 1Polycystic Ovary Syndrome 1Overweight 1Obesity 1Insulin Resistance 1Craniopharyngioma 1

Interventions

Radiotherapy 2Proton Therapy 2Mental Status and Dementia Tests 2trametinib 1tozuleristide 1tovorafenib 1tocilizumab 1dabrafenib 1cobimetinib 1binimetinib 1antineoplaston AS 2-1 1antineoplaston A10 1Vemurafenib 1Transurethral Resection of Bladder 1Surgical Procedures, Operative 1Qsymia 1Phentermine 1Oxytocin 1Methionine 1Memantine 1Medication Errors 1Ginkgo biloba extract 1Exenatide 1Donepezil 1Contrast Media 1CKD732 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Craniopharyngioma × Exenatide × Clear all
NCT01484873 2017-03-03

Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor

Vanderbilt University Medical Center

Phase 2 Completed
10 enrolled 15 charts
CNSOther

Craniopharyngioma, Obesity, Sexual Infantilism, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡